Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias

J Am Coll Cardiol. 2007 May 22;49(20):2035-43. doi: 10.1016/j.jacc.2007.01.085. Epub 2007 May 4.

Abstract

Objectives: This study sought to compare and contrast the clinical and electrophysiological characteristics of outflow tract arrhythmias.

Background: Idiopathic ventricular outflow tract arrhythmias manifest clinically in 3 forms: 1) paroxysmal sustained monomorphic ventricular tachycardia (SMVT), 2) repetitive nonsustained ventricular tachycardia (NSVT), or 3) premature ventricular contractions (PVCs). Although these arrhythmias have a similar site of origin, it is unknown whether they share a common mechanism or similar clinical features.

Methods: A total of 127 patients (63 female [50%], mean age 51 +/- 15 years) were evaluated for outflow tract arrhythmias.

Results: A total of 36 (28%) presented with the index clinical arrhythmia of SMVT, 46 (36%) with NSVT, and 45 (35%) with PVCs. The sites of origin of the arrhythmias were similar among the 3 groups, occurring in the right ventricular outflow tract in 82%. Sustained ventricular tachycardia was more likely to be induced during exercise in the SMVT (10 of 15 patients [67%]) than NSVT or PVCs groups (p < 0.01). Sustained outflow tract ventricular tachycardia was induced at electrophysiology study in 78% of SMVT patients, 48% of NSVT patients, and 4% of PVCs patients. Adenosine was similarly effective in all 3 groups (p = NS).

Conclusions: Patients with outflow tract arrhythmias can be differentiated based on the subtype of arrhythmia. However, the observation that approximately 50% of patients with NSVT and approximately 5% of patients with PVCs have inducible sustained ventricular tachycardia that behaves in an identically unique manner to those who present with sustained ventricular tachycardia (e.g., adenosine-sensitive) suggests that rather than representing distinct entities, outflow arrhythmias may be considered a continuum of a single mechanism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / therapeutic use
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Arrhythmia Agents / therapeutic use
  • Child
  • Electrocardiography*
  • Electrophysiologic Techniques, Cardiac*
  • Exercise Test
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / physiopathology*
  • Ventricular Premature Complexes / physiopathology*
  • Verapamil / therapeutic use

Substances

  • Anti-Arrhythmia Agents
  • Verapamil
  • Adenosine